QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: a case report
Article in Frontiers in Pharmacology (May 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (May 2024)
Article in Journal of Gynecologic Oncology (March 2024)